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Abstract
Mediation analysis allows one to use observational data to estimate the importance of each
potential mediating pathway involved in the causal effect of an exposure on an outcome. How-
ever, current approaches to mediation analysis with multiple mediators either involve assump-
tions not verifiable by experiments, or estimate the effect when mediators are manipulated
jointly which precludes the practical design of experiments due to curse of dimensionality,
or are difficult to interpret when arbitrary causal dependencies are present. We propose a
method for mediation analysis for multiple manipulable mediators with arbitrary causal de-
pendencies. The proposed method is clinically relevant because the decomposition of the total
effect does not involve effects under cross-world assumptions and focuses on the effects after
manipulating (i.e. treating) one single mediator, which is more relevant in a clinical scenario.
We illustrate the approach using simulated data, the “framing” dataset from political science,
and the HIV-Brain Age dataset from a clinical retrospective cohort study. Our results provide
potential guidance for clinical practitioners to make justified choices to manipulate one of the
mediators to optimize the outcome.
1 Introduction
Inferring causal effects and the mediating pathways from observational and/or experimental data
is one of the most important problems in healthcare and artificial intelligence (1). In animal and
some human studies, it is possible to conduct a randomized controlled trial (RCT) to infer the
causal effect of a particular intervention on an outcome. RCTs are considered the gold standard
of causal inference given their ability to limit/reduce multiple sources of bias (2). However, an
RCT may not be feasible or ethical for certain interventions. In these cases, researchers must
conduct observational studies instead and adjust for potential biases using statistical methods.
Advances in statistical methods in causal inference (3; 4; 5; 6) have led to the possibility of studying
causal effects in a mathematically principled way using observational data to guide healthcare
practice. These methods often allow estimating causal effects in settings where subjects were
assigned to an exposure non-randomly based on their characteristics such as age or disease severity
at admission (4). Note that throughout this paper we will use the word “exposure” instead of
“intervention” or “treatment”. “Exposure” is more general which includes intervention or treatment,
or observational factors such as a disease. We use the terminology from the potential outcomes
framework developed by Neyman, Rubin, and Robins (7; 8; 9): when the assignment is equal to the
observed exposure, the outcome is called “factual outcome”; otherwise it is called “counterfactual
outcome”; either of which is called “potential outcome”.
Mediation analysis is an important sub-field of causal inference. It aims at measuring the
relative importance of each mediating pathway, by decomposing the total effect (TE) into parts
including mediation due to mediators, and interactions due to the co-existence of exposure and
mediators (10; 11). The mediators are defined as those causally affected by the exposure, while
also causally affecting the outcome. The categorization of a variable as being a mediator or a
confounder is determined by human knowledge or temporal ordering, if any. The total effect can
be decomposed in various ways including
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(1) controlled direct effect and eliminated effect;
(2) natural direct effect and natural indirect effect (12); and
(3) 4-way decomposition: controlled direct effect, reference interaction, mediated interaction,
and pure indirect effect (10).
The extension of these approaches into multiple mediators with arbitrary causal dependency
is challenging: For decomposition (1), the eliminated effect represents all effects other than the
controlled direct effect (13) which cannot be contributed to each mediator. For decomposition (2),
although the division into natural direct and indirect effects is simple and can be done even in
the presence of interaction, this decomposition involves cross-world effects (nested counterfactuals
with different exposures), which does not correspond to any randomized experiment performed
via interventions on the exposure and/or mediator (13); the identification of these effects also
requires a strong “sequential ignorability” assumption which rules out the possibility of assessing
each mediator when they are causally dependent (14). For decomposition (3), the pure indirect
effect in the case of multiple mediators requires estimating the joint potential outcome, i.e. the
potential outcome when the exposure and all mediators would have been set to particular values,
which is not clinically practical and suffers from the curse of dimensionality when the number of
mediators is large.
In this work, we propose a “clinically relevant” mediation analysis approach to decompose
the total effect for multiple manipulable mediators with arbitrary causal dependencies, which
overcomes the above limitations. Note that we limit the scope to binary exposure and mediator.
Here, clinical relevance means (1) the mediators are manipulable, such as treating a co-morbidity
(mediator) of a disease (exposure); (2) the decomposition involves terms related to the effect
due to one mediator being treated, which mimics clinical practice that a physician might focus
on treating one mediator at one time, rather than treating all mediators jointly. Intervening on a
single mediator makes it possible to rank mediators (comorbidities) based on their CIE (the change
in the outcome if everyone’s k-th comorbitidy is treated). So that we can make decision to give
priority to the top mediators (comorbidities) to spend resources (doctor’s attention, medication,
research). Since CIE can be viewed as the total effect of mediator on outcome, its effect includes
the downstream mediators in case of multiple mediators and confounders; In terms of multiple
mediators and confounding, CIEk includes all its downstream effect, in other words, CIEk is the
total effect of treating the k-th mediator on the outcome.; and (3) there is no cross-world effects,
and thus all the quantities in our decomposition can be experimentally validated, such as using the
parallel (encouragement) experiment design (15). In particular, we propose decomposing the total
effect into two components for each mediator: the “controlled direct effect”; and “scaled controlled
indirect effect” which is a function of CIE (CIE is the effect due to one mediator being treated).
Causal inference and mediation analysis make up an under-represented but scientifically valu-
able field in artificial intelligence and machine learning applied to healthcare. They help healthcare
practitioners and researchers understand the underlying data-generating mechanisms by prospec-
tively or retrospectively observing patients. In general, machine learning algorithms that take
causality into account have great potential to guide decision-making in healthcare based not on
association but on causality, improving the algorithm performance and transferability to different
settings since the causal mechanisms are stable (16). The approach developed in this paper pro-
vides a new method for mediation analysis that, when applied to a clinical problem, can provide
insight into the consequences of preventing or treating a co-morbidity that mediates the effect of a
particular disease on a particular outcome. This is a core problem in medicine; much of medicine
is devoted to mitigating the effects of a disease by treating a resultant co-morbidity. Our method
provides an improved way to quantify the possible effect, or clinical benefit, of such a mitigation
strategy on downstream clinical outcomes. Additionally, by allowing arbitrary causal dependen-
cies among multiple mediators, this provides flexibility for a clinician to consider the mediator of
interest in clinically realistic scenario.
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2 Related Work
The existing works mostly focus on the extension of decomposition (2), i.e. the natural direct
and indirect effect approach. (17) and (18) extend it to multiple mediators by considering all
mediators jointly as one vector-valued mediator, so that the “sequential ignorability” assumption
(no exposure-induced mediator-outcome confounder) still holds. (19) still estimates the indirect
effect of each mediator (although the “sequential ignorability” assumption is violated), but uses
sensitivity analysis to assess the robustness of their results to the violation of the assumption. As we
mentioned above, this approach is not clinically relevant since the natural effects cannot be verified
by any experiment. There are also works focusing on the extension of decomposition (3). (20)
extends the 4-way decomposition to the finest decomposition that unifies multiple mediators and
interactions for causally independent mediators. With more mediators, it becomes incrementally
difficult to define, identify, and estimate these components.
Our approach is closer to the interventional effect approach in (18; 21; 22). The interventional
indirect effect is defined as the contrast in the outcome if we fix the exposure, while changing the
mediator from a sampled value from the distribution of the mediator among all subjects with one
exposure to a sampled value from the distribution from another exposure. However, the sum of
interventional direct and indirect effect is not equal to the total effect. In contrast, in our appraoch,
the controlled direct effect and the scaled controlled indirect effect add up to the total effect. And
we fix the mediator to 0 or 1 for the ease of clinical practice.
3 Methods
We use Y to denote the outcome, e.g. mortality, cognitive test score, or a physiological measure-
ment. A denotes the exposure (e.g. taking a pill, infection with HIV or coronavirus, or developing
a disease such as Alzheimer’s). Mk denotes the k-th mediator, e.g. a co-morbid medical condition
which worsens the outcome. L denotes the set of covariates, e.g. a patient’s age, gender, race,
smoking status, and years of education. Here we limit the scope to binary A and M ; Y is discrete
or continuous; and L is a vector of any type of variable. There are K mediators.
3.1 Total Effect Decomposition
In general, given a causal DAG, the total effect (TE) can be decomposed into (proof in Appendix A)
TE = CDEk(0) + sCIEk for k = 1, . . . ,K , (1)
where
CDEk(0) = Yk(1, 0)− Yk(0, 0) ; (2)
sCIEk = Mk(1)CIEk(1)−Mk(0)CIEk(0) ; (3)
CIEk(a) = Yk(a, 1)− Yk(a, 0) ; (4)
Yk(a,m) = Y (a,M1(a), · · · ,Mk−1(a),m,Mk+1(a), · · · ,MK(a)) ; (5)
Mk(a) = Mk (a, Pa{Mk}(a)) . (6)
Here we denote Y (A = a,Mk = m), or simply Yk(a,m), as the potential outcome of Y when A
would have been a, the k-th mediator would have been m, and the other mediators were behaving
as if A was a. CDEk(0) is the controlled direct effect for the k-th mediator, defined as the contrast
in the potential outcome when the exposure changes from 0 to 1, while fixing the k-th mediator to
be 0; other mediators were behaving as if A was a. sCIEk is the scaled controlled indirect effect for
the k-th mediator, defined as the controlled indirect effect scaled by the potential outcome of the
k-th mediator when fixing the exposure to 1, subtracting the same quantity but when fixing the
exposure to 0. CIEk(a) is the controlled indirect effect of the k-th mediator, defined as the contrast
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in the potential outcome when the k-th mediator changes from 0 to 1, while fixing the exposure to
a and other mediators were behaving as if A was a. Pa{Mk}(a) = {Mj(a)}j∈Parent of Mk which is
the set of causal parents of the k-th mediator in the given DAG.
Note that there is no cross-world potential outcome such as Mk(1, Pa{Mk}(0)). Also note that
Equation (6) is a recursive definition: if there is no parent for Mk, it is just Mk(a); if there is a
parent mediator M1 of Mk, Mk(a) = Mk(a,M1(a)); if M2 is a parent of M1 and M1 is a parent
of Mk, Mk(a) = Mk(a,M1(a),M2(a,M1(a))); and so forth. If the k-th mediator is not causally
affected by the exposure, the a in the parenthesis can be dropped.
We have the following corollary (proof in Appendix B):
Corollary 3.0.1
TE =
1
K
K∑
k=1
CDEk(0) +
1
K
K∑
k=1
sCIEk , (7)
which shows the total effect can also be decomposed as the average of the CDEs of all mediators,
and the average of the sCIEs of all mediators, reflecting the average percentage of direct and
indirect effects across all mediators. This corollary also provides an alternative way to estimate
the total effect, which could serve as a less biased estimate by canceling the model mis-specification
biases from each single mediator. This is a trade of precision for accuracy, because the estimate of
the average sCIE is improved, but knowing the contribution of any particular mediator is lost.
3.2 Interpretation of the Scaled Controlled Indirect Effect
Suppose (omitting subscript k)
M(1) = M(0) + ∆M ; (8)
CIE(1) = CIE(0) + ∆C . (9)
We can look at the extreme cases
sCIE = ∆M · CIE(0) = ∆M · CIE(1) if ∆C = 0 ; (10)
sCIE = ∆C ·M(0) = ∆C ·M(1) if ∆M = 0 . (11)
When ∆C = 0, i.e. CIE(0) = CIE(1), hence no interaction between the mediator and exposure,
sCIE only contains the mediated effect which is the difference in the outcome if that mediator is
changed from 0 to 1, scaled by the increase in the probability of the mediator. When ∆M = 0, i.e.
M(0) = M(1), hence no mediation, sCIE only contains the interaction between the mediator and
the exposure, scaled by the constant probability of the mediator. Therefore when ∆M 6= 0 and/or
∆C 6= 0, sCIE is a mixture of mediation and interaction effects. In contrast, CIE is the total effect
of mediator on the outcome.
3.3 Identification Assumptions
There are three assumptions needed to identifyMk(a) and Yk(a,m), and hence CDEk(0), CIEk(a),
and sCIEk, from observational data.
1. Consistency assumption: an individual’s potential outcome under the observed exposure is
equal to the observed outcome
M
(i)
k (a) = M
(i)
k if A
(i) = a ; (12)
Y
(i)
k (a,m) = Y
(i) if A(i) = a,M (i)k = m . (13)
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Consistency may be violated if there are multiple versions of exposure (23). It is unlikely the case
in the “framing” dataset. In the case of the HIV-BA dataset, although there are multiple ways to
contract HIV-1, we consider HIV-1 infection status as a single exposure because the viral processes
in the body following infection are generally similar across patients.
2. Positivity assumption: there is a positive probability of receiving every level of exposure for
every combination of values of exposure, mediator of interest, and confounding variables in the
population. Usually, large sample size can alleviate this assumption. Positivity assumption is an
important assumption for weighting based estimation methods such as inverse propensity weight
and doubly robust estimation.
3. Ignorability assumption: the exposed and unexposed subjects have equal distributions of
potential outcomes when conditioned on confounding variables. This is sometimes referred as
exchangeability assumption.We need two ignorability assumptions:
Mk(a) ⊥ A |L ; (14)
Yk(a,m) ⊥ A,Mk |L . (15)
These assumptions can be equivalently expressed as the causal DAG is correct. Hence, we can prove
the above equations for multiple mediators with arbitrary causal dependency using d-separation in
the single world intervention graph (SWIG) (24). The proof is given in Appendix C. Note that we
are not using natural direct or indirect effect, therefore the much stronger sequential ignorability
assumption is not needed (14).
3.4 Effect Estimation
CDE, CIE and sCIE are defined as functions of Mk(·) and Y (·), which need to be estimated from
data. Therefore, the unbiasedness property (consistency, zero bias in the limit of infinite data,
not to be confused with the consistency assumption in Section 3.3 for causal inference) partially
depends on the unbiasedness of Mk(·) and Y (·) (other than other biases such as selection bias or
measurement error).
To this end, we can use doubly robust estimation (25), which entails less biased estimation.
The doubly robust property is described by a class of models which admits a doubly robust first
order influence function (26). Their influence function has the form of product of two models’
influence functions. For example, suppose Y and A are univariate random variables that are
dependent on observed data X, the expected product of two conditional expectations ψ(θ) =
Eθ[Eθ[Y |X] · Eθ[A|X]] is a doubly robust estimator (27); the other well-known example is the
doubly robust estimator for the total effect (average treatment effect), which is unbiased if at least
one of the outcome (f function below) or propensity model (g function below) is unbiased.
The doubly robust estimator is written as
Mk(a) ≈ 1
N
N∑
i=1
[
f
(i)
M,k +
1(A(i) = a)
g
(i)
M
(
M
(i)
k − f (i)M,k
)]
; (16)
Yk(a,m) ≈ 1
N
N∑
i=1
[
f
(i)
Y,k +
1(A(i) = a,M
(i)
k = m)
g
(i)
Y,k
(
Y (i) − f (i)Y,k
)]
. (17)
where
f
(i)
M,k = E
[
Mk|A = a, L(i)
]
; (18)
f
(i)
Y,k = E
[
Y |A = a,Mk = m,L(i)
]
; (19)
g
(i)
M = P (A
(i)|L(i)) ; (20)
g
(i)
Y,k = P (M
(i)
k |L(i), A(i))P (A(i)|L(i)) . (21)
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3.5 Model Selection and Fitting
Here we used the principled approach introduced in (27). In estimating either TE of exposure on
outcome, or CIE (TE of of mediator on outcome), we want to minimize the bias E[ψ′ − ψ], where
ψ is the ground truth TE and ψ′ is the estimated TE. Directly minimizing this bias is impossible
due to unknown ψ. Instead, we minimize a pseudo-risk over different choice of models, where the
optimal model choice is least sensitive to perturbations due to model mis-specification. Here we
used the mixed minmax solution, which is proved to have a doubly robust property, i.e. zero bias
if at least one candidate estimation model is correctly specified. Here, we choose from (1) `2-norm
penalized linear regression or logistic regression; (2) `2-norm penalized support vector machine
(SVM) classifier; (3) random forest; and (4) XGBoost, a type of gradient boosting tree. For the
ordinal outcome in the framing dataset introduced later, we used pairwise approach (28) to convert
ordinal regression problem into binary classification and then solved using the above models.
We used nested cross-validation to fit the models. Nested cross-validation consists of an inner
loop and an outer loop. The purpose of the outer loop is to compute an unbiased estimate when
applied to data not part of the training set. The purpose of the inner loop was to find the best
hyper-parameter, C the strength of `2-norm penalty, to avoid overfitting. The outer loop divided
the data into multiple folds. Each fold was used as the testing set, while the other folds were
combined and further divided into inner folds. Each inner fold was used as the validation set,
while the other inner folds were combined as the training set. The model was trained with a
particular C on the training set and evaluated on the validation set. The C with the best average
validation performance was chosen and re-fit using the combined training and validation sets. The
model was then used to estimate the causal effects on the testing set. The final reported effects
were the average effects on the testing sets from the outer loop. The confidence intervals were
obtained using bootstrapping 1,000 times.
4 Results
4.1 Dataset
The simulated data is generated based on the causal ordering implicated by the DAG, i.e. L −→
A −→ M −→ Y . Each variable is generated as a generalized linear function of its causal parents
plus noise. We first randomly generate the coefficients, take the inner product between the coef-
ficients and causal parents plus intercept. The intercept is manually chosen to make the average
of the inner product zero. We then added Gaussian noise with standard deviation 1. For binary
variables such as A and M , we further applied the sigmoid transformation, and binarized it using
a threshold of 0.5. The sample size N is 1,000; the number of covariates in L is 2; and the number
of mediators in M is 2 or 3 depending on the DAG we study.
We also used a public dataset “framing” used in the R package “mediation” (14). The detailed
description of the framing data can be found in (29). It is a randomized experiment in which
the subjects are shown immigration stories with different framing. The exposure is whether the
story is framed positively and features an European immigrant. The covariates include age, gender,
education level, and income. The mediators include negative emotion and perceived harm. Emotion
measures subjects’ negative feeling, and is converted to 1 if more or equal to 8. Perceived harm is
with respect to increased immigration, and is converted to 1 if more or equal to 7. The outcome is
a four-point scale measuring the attitudes toward increased immigration. There are 265 subjects
in this dataset. Note that since the exposure is randomized, we used outcome regression instead
of doubly robust estimation for this dataset.
The “HIV-Brain Age” (HIV-BA) dataset comes from a retrospective cohort study which inves-
tigates the effect of HIV-1 infection (exposure) on brain age index (BAI) predicted by the sleep
electroencephalogram (EEG) (30) (outcome) through multiple mediating comorbidities and side-
effects. The outcome BAI is in unit of years, and bigger value represents older age, hence worse
outcome. The cohort is composed of participants with a possible sleep disorder who underwent
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a full-night diagnostic sleep study at a hospital’s sleep lab. The HIV+ subset were those who
were diagnosed with HIV infection prior to their sleep study and are currently on antiretroviral
therapy based on clinical chart review. The HIV- subset never had HIV infection. The exposure
is HIV infection (binary). The covariates are age, gender, race, alcoholism and smoking history.
The mediators are hyperlipidemia, heart valve disorders, and insomnia (all binary). The outcome
is the brain age index, which is a continuous number in unit of years. There are 43 HIV+ and
3,048 HIV- subjects.
4.2 Causally Independent Mediators
We assume two causally independent mediators as shown in Figure 1. It represents the case that
A takes effect on Y through two independent mechanisms M1 and M2. Note that here we use the
example of 2 mediators, but in general it can be multiple.
L
A Y
M2
M1
Figure 1: Causal graph with independent mediators. The arrows represent causal influences. M1
and M2 are the first and second mediators respectively.
4.2.1 Simulation experiments
The results are shown in Table 1. The model selection method described in Section 3.5 correctly
selected linear models (logistic regression and linear regression) for the propensity models and
outcome models when estimating Mk(a) and Yk(a,m). By "correct" we mean that the data is
generated using a generalized linear model. Since this is simulated data, we can get the ground
truth effects by directly manipulating A and M ’s. All effects except CDE for M1 and M2 and the
total effect for M1 is within the 95% confidence interval. The bias in estimating CDE, and hence
in total effect, is due to the bias in the estimated coefficient when using the `2 penalized linear
models. The confidence interval for sCIE is in general wider than that for CIE because sCIE is a
function of CIE(a) and M(a) which jointly considers the exposure and mediator.
Table 1: The estimated effects and their ground truth value for the simulated data with independent
mediators
Effect M1
M1 True Effect
from Simulation M2
M2 True Effect
from Simulation
%CDE 78.5 [67.2 – 90.3] 93.9 72.4 [61.7 – 82.9] 87.4
%sCIE 21.5 [9.7 – 32.8] 6.1 27.6 [18.0 – 38.3] 12.6
CDE 0.99 [0.75 – 1.24] 1.15 0.95 [0.73 – 1.17] 1.07
sCIE 0.27 [0.12 – 0.42] 0.075 0.36 [0.22 – 0.53] 0.16
TE 1.27 [1.00 – 1.53] 1.23 1.31 [1.09 – 1.60] 1.23
CIE0 4.04 [3.72 – 4.35] 4 4.71 [4.44 – 5.00] 5
CIE1 4.10 [3.78 – 4.39] 4 4.84 [4.56 – 5.11] 5
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4.2.2 Framing dataset
For the framing dataset, we used emotion and perceived harm as the two independent mediators.
The model selection method selected linear SVM for the outcome models when estimating Yk(a,m)
(outcome regression is used since the exposure is assigned at random). The result is shown in
Table 2, which is consistent with the finding that emotion (35.6% sCIE) is a leading mediator
compared to perceived harm (18.8% sCIE) when people are making decisions about immigration.
But interestingly, the CIE of perceived harm is higher than emotion. In other words, directly
reducing perceived harm could be more effective than directly improving the negative emotion
(directly intervene the mediator), but it is more difficult to induce perceived harm than to induce
negative emotion using different ways of framing (change mediator by intervening the exposure),
due to the scaling of mediation effect as well as interaction effect (Equation (10) and (11)). The total
effect estimated in (14) Section 6.2 is 0.42 (95% confidence interval [0.17–0.62]). Our estimation is
0.31 to 0.36.
Table 2: The estimated effects for the framing dataset when assuming independent mediators
Effect Emotion (M1) Perceived Harm (M2)
%CDE 43.4 [-119.6 – 105.1] 61.0 [-76.0 – 186.0]
%sCIE 56.6 [-5.1 – 219.6] 39.0 [-86.0 – 176.0]
CDE 0.16 [-0.12 – 0.77] 0.19 [-0.12 – 0.86]
sCIE 0.20 [-0.014 – 0.29] 0.12 [-0.13 – 0.20]
TE 0.36 [0.026 – 0.81] 0.31 [-0.038 – 0.79]
CIE0 0.74 [0.41 – 1.22] 1.03 [0.58 – 1.43]
CIE1 0.79 [0.38 – 1.10] 1.05 [0.51 – 1.29]
4.3 Causally Dependent Mediators
We assume three causally dependent mediators as shown in Figure 2. It represents the case that
A has an effect on Y through three mechanisms M1, M2, and M3, while M1 also causes M2 and
M3, and M2 also causes M3. Note that here we use the example of 3 mediators, but in general it
can be multiple and arbitrary causal dependencies as long as there are no cycles.
L
A Y
M
M1
M2
M3
Figure 2: Causal graph with dependent mediators. The arrows represent causal influences. Here
we use an example of 3 mediators. M1, M2, and M3 are the mediators which are causally affected
as in the figure. Both L and A causally affect each mediator; each mediator causally affect the
outcome Y .
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4.3.1 Simulation experiments
In Table 3 we show the result. The model selection method described in Section 3.5 again correctly
selected linear models (logistic regression and linear regression) for the propensity models and
outcome models when estimating Mk(a) and Yk(a,m). Since this is simulated data, we can get
the ground truth effects by directly manipulating A and M ’s. The true effects are within the 95%
confidence interval forM1 andM3. M2 tends to overestimate the indirect effect and underestimate
the direct effect.
Table 3: The estimated effects and their ground truth value for the simulated data with dependent
mediators
Effect M1
M1 True
Effect M2
M2 True
Effect M3
M3 True
Effect
%CDE 89.057 [79.7 – 97.9] 92.5 85.6 [57.0 – 100.1] 86.5 90.9 [82.0 – 103.1] 92.4
%sCIE 10.9 [2.1 – 20.3] 7.5 14.4 [-0.13 – 43.0] 13.5 9.1 [-3.12 – 18.0] 7.6
CDE 1.17 [0.87 – 1.43] 1.26 1.24 [0.44 – 1.59] 1.15 1.24 [0.89 – 1.70] 1.21
sCIE 0.14 [0.028 – 0.26] 0.10 0.21 [0.001 – 0.64] 0.18 0.13 [-0.041 – 0.24] 0.1
TotalEffect 1.31 [1.04 – 1.59] 1.36 1.45 [0.74 – 1.79] 1.33 1.37 [1.02 – 1.71] 1.31
CIE0 2.82 [2.56 – 3.09] 3.75 1.77 [1.27 – 2.19] 2.18 1.16 [0.84 – 1.50] 1
CIE1 2.83 [2.57 – 3.10] 3.81 1.77 [1.40 – 2.46] 2.2 1.06 [0.66 – 1.40] 1
4.3.2 HIV-Brain age dataset
People with HIV take antiretroviral therapy drugs, where some of the drugs, such as Lopinavir,
Saquinavir, and Stavudine is associated with high cholesterol level in the blood (hyperlipidemia) (31),
which in turns increases the risk of heart disorders such as heart valve disorder (32), and eventu-
ally leads to sleep disorders such as insomnia. Therefore, in this case M1 is hyperlipidemia; M2 is
heart valve disorder; and M3 is the insomnia. The model selection method selected linear models
(logistic regression for exposure and linear regression for outcome) when estimating Mk(a) and
Yk(a,m).
Table 4: The estimated effects (in years of brain age) for the HIV-BA dataset when assuming
multiple dependent mediating comorbidities
Effect Hyperlipidemia (M1) Heart valve disorder (M2) Insomnia (M3)
%CDE 13.7 [-73.8 – 124.3] 44.3 [-48.3 – 134.3] 89.8 [-29.6 – 413.5]
%sCIE 86.3 [-24.3 – 173.8] 55.7 [-34.3 – 148.3] 10.2 [-313.5 – 129.6]
CDE 0.69 [-1.16 – 3.19] 2.07 [-1.16 – 5.20] 3.24 [-0.018 – 6.22]
sCIE 4.36 [-0.55 – 8.22] 2.60 [-0.82 – 7.00] 0.37 [-3.07 – 7.01]
TE 5.06 [0.45 – 8.58] 4.67 [0.84 – 8.49] 3.60 [0.081 – 8.97]
CIE0 -0.87 [-1.84 – -0.002] 2.05 [0.86 – 3.19] 0.73 [-0.15 – 1.60]
CIE1 5.35 [-1.21 – 9.84] 7.22 [-1.16 – 14.4] 0.84 [-5.05 – 11.12]
The results indicate that hyperlipidemia is an important comorbidity in HIV+ subjects. The
relatively large CIE means that directly treating hyperlipidemia has an substantial effect on brain
age index in HIV+ subjects; the relatively large sCIE means that HIV infection itself can sub-
stantially increases the prevalence of hyperlipidemia, which subsequently has both high mediation
and interaction effects on brain age index. Heart valve disorder also has relatively large CIE; but
smaller sCIE, indicating the relatively weaker increase in the prevalence of heart valve disorder due
to HIV infection and hyperlipidemia and the interaction with them. On the other hand, insomnia
has limited effect on brain age index compared to hyperlipidemia and heart valve disorder. Due to
the limited number of 43 HIV+ subjects, the confidence interval is very wide for HIV+ subjects,
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indicating the importance of having enough samples for mediation analysis (detailed in Limitations
in Section 5).
5 Discussion
We have presented a clinically relevant method of mediation analysis with multiple manipulable
mediators and arbitrary causal dependency, using observational data. Our approach is clinically
relevant because it makes the observational data useful for doctors to think about clinical decision-
making, as detailed in the following aspects: Since the decomposition eliminates cross-world con-
siderations, the effects are directly related to what would happen if they took a particular course
of action to treat one comorbidity. The elimination of cross-world considerations is also a lead-in
to confirmation of a hypothesis in a clinical trial. It is also clinically practical since the controlled
indirect effect focuses on the effect of manipulating (treating) one single mediator rather than all
of them jointly.
Alternative interpretations of the scaled controlled indirect effect We have
sCIE = (M(0) + ∆M)(CIE(0) + ∆C)−M(0)CIE(0)
= ∆C ·M(0) + ∆M · CIE(0) + ∆M ·∆C
= ∆C ·M(0) + ∆M · CIE(1) . (22)
The last equation shows the consequences of reducing ∆M . The meaning of reducing ∆M
is intuitive. If a certain medication or preventive measure reduces the risk of the mediator by a
known percent, that percent multiplied by CIE(1) is the amount of outcome prevented, averaged
across the exposed population. On the other hand, sCIE can also be viewed as the effect of the
mediator of interest on the outcome in the exposed population (∆M ·CIE(1)) beyond the baseline
level of exposure-mediator interaction in the unexposed population (∆C ·M(0)).
Cross validation and model estimation in causal inference Regularization and using cross
validation to select the regularization strength is in general not advised in effect estimation, since
the loss function of regularized models do not respect the target causal effect. The idea of us-
ing perturbation as a pseudo-risk, as used in Section 3.5, represents a possible direction. Other
possibilities include optimizing regularization that improves the consistency assumption, such as
minimizing the difference between the factual branch of model-based potential outcome vs. the
observed value, such as in (33).
Extension to path-specific analysis Path-specific analysis is an extension to mediation anal-
ysis by looking at the effect mediated by a path (a bundle of nodes and edges) (34). Longi-
tudinal setting represents a typical use case in path-specific analysis (35). The idea is TE=
(Y (a) − Ypi) + (Ypi − Y (a′)), where Ypi is the effect specific to path pi. The decomposition is
analogous to TE=[Y (a,M(a)) − Y (a,M(a′))] + [Y (a,M(a′) − Y (a′,M(a′))] =NIE+NDE, which
still requires cross-world counterfactuals. In contrast, our approach represents a “controlled” fla-
vor, vs. “natural” flavor, which is TE = CDE+sCIE = CDE(0)+f(CIE(1), CIE(0)), and may be
extended to TE = [Y (a, do(Mpi = 0))−Y (a′, do(Mpi = 0))] + f [Y (a, do(Mpi = m))−Y (a, do(Mpi =
m′)), Y (a′, do(Mpi = m)) − Y (a′, do(Mpi = m′))]. The controlled flavor has the advantages that
CIE directly simulates what if the mediator path are intervened, answering the clinically relevant
question: what if I intervene the mediating path? The disadvantage is that CIE is TE of the
mediator on outcome, which is subject to unmeasured confounding. The natural flavor has the
advantage that it deals with unmeasured confounding, but NIE and NDE cannot be interpreted
in the clinical relevant way. As an important future work, extension of the controlled flavor into
path-specific effects is needed.
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Limitations First, our analysis is limited to the case where both A and M are binary (0 or
1) making it restrictive in applications. Although it is a helpful simplification to indicate if the
mediator (comorbidity) is treated or not, in reality comorbidities can be reduced without being
fully treated. Second, we have not considered other types of contrast. In the present work we have
focused on the difference between two potential outcomes. But depending on the data type of Y
and M , different decomposition equations need to be derived and validated.
The analysis of HIV-BA dataset is limited in terms of the number of HIV+ patients. Mediation
analysis requires a relatively large sample size. This is because mediation analysis divides the data
into multiple strata, i.e. samples with and without the presence of each mediator in both exposed
and unexposed groups. And there should be enough samples in each stratum to reduce sampling
bias. In the case of nested cross-validation, the sample size should be even larger to make sure each
fold in the inner loop has enough samples. The fact that our approach deals with each mediator
one by one reduces the need for large sample size so that the samples need not grow with the
number of mediators. This is helpful but does not completely resolve this limitation. Monte Carlo
based power analysis can be done by generating the data using models estimated from actual data,
up to the point significance is shown (36).
Other limitations are, as in all causal inference studies, we did not consider all potential biases in
the real data examples, including (1) unmeasured confounding, i.e. incomplete or incorrect variable
list in L. We have not done sensitivity analysis to address this; (2) selection bias, especially in
the HIV-BA dataset, the dataset comes from a hospital sleep lab, where the prevalence of sleep
disorders is higher than that in the general population; and (3) measurement noise, i.e. possible
subjectivity in the framing dataset, and measurement noise in predicted brain age in the HIV-BA
dataset since it is based on a single night of brain activity monitoring, not multiple.
6 Conclusion
The proposed approach can be used to assess the importance of multiple manipulable mediators
with arbitrary causal dependencies. In the case of healthcare problems where the mediators are
comorbidities or side-effects of certain exposures, our approach provides principled guidance for
choosing which mediator to treat in order to optimize the healthcare outcome.
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Supplemental Material
A Proof of Equation (1)
We have the total effect as
TE = Y (a = 1)− Y (a = 0)
= Y (1)− Y (0)
= Y (1,M1(1, Pa{M1}(1)), · · · ,MK(1, Pa{MK}(1)))
− Y (0,M1(0, Pa{M1}(0)), · · · ,MK(0, Pa{MK}(0))) . (23)
Expanding the k-th mediator, we have
Y (1) = Y (1,M1(1, Pa{M1}(1)), · · · ,MK(1, Pa{MK}(1)))
= Y (1,M1(1, Pa{M1}(1)), · · · , 1, · · · ,MK(1, Pa{MK}(1)))Mk(1, Pa{Mk}(1))
+ Y (1,M1(1, Pa{M1}(1)), · · · , 0, · · · ,MK(1, Pa{MK}(1))) (1−Mk(1, Pa{Mk}(1)))
= Y (1,M1(1, Pa{M1}(1)), · · · , 0, · · · ,MK(1, Pa{MK}(1)))
+Mk(1, Pa{Mk}(1))
[
Y (1,M1(1, Pa{M1}(1)), · · · , 1, · · · ,MK(1, Pa{MK}(1)))
− Y (1,M1(1, Pa{M1}(1)), · · · , 0, · · · ,MK(1, Pa{MK}(1)))
]
= Y (1,M1(1, Pa{M1}(1)), · · · , 0, · · · ,MK(1, Pa{MK}(1))) +Mk(1, Pa{Mk}(1))CIEk(1) .
(24)
Similarly, we have
Y (0) = Y (0,M1(0, Pa{M1}(0)), · · · ,MK(0, Pa{MK}(0)))
= Y (0,M1(0, Pa{M1}(0)), · · · , 0, · · · ,MK(0, Pa{MK}(0))) +Mk(0, Pa{Mk}(0))CIEk(0) .
(25)
Therefore,
TE = Y (1)− Y (0)
=
[
Y (1,M1(1, Pa{M1}(1)), · · · , 0, · · · ,MK(1, Pa{MK}(1)))
− Y (0,M1(0, Pa{M1}(0)), · · · , 0, · · · ,MK(0, Pa{MK}(0)))
]
+
[
Mk(1, Pa{Mk}(1))CIEk(1)−Mk(0, Pa{Mk}(0))CIEk(0)
]
=
[
Yk (1, 0)− Yk (0, 0)
]
︸ ︷︷ ︸
CDEk(0)
+
[
Mk(1)CIEk(1)−Mk(0)CIEk(0)
]
︸ ︷︷ ︸
sCIEk
. (26)
B Proof of Corollary 3.0.1
Equation (24) and (25) are general equations obtained by expanding the k-th mediator. We repeat
this for all mediators 1, . . . , K, so that
TE = CDE1(0) + sCIE1 ; (27)
· · ·
TE = CDEK(0) + sCIEK . (28)
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Therefore,
TE =
1
K
K∑
k=1
CDEk(0) +
1
K
K∑
k=1
sCIEk . (29)
C Proof of Ignorability
We can graphically prove Equation (14)Mk(a) ⊥ A |L by constructing the single world intervention
graph (SWIG) as in Figure 3b. The conditional independence is true since all connections between
Mk(a) and A must go through L, which is blocked by conditioning on L based on d-separation.
We can also graphically prove Equation (15) Yk(a,m) ⊥ A,Mk |L by constructing the SWIG
as in Figure 3c. The conditional independence is true since all connections between Yk(a,m) and
A,Mk must go through L, which is blocked by conditioning on L based on d-separation.
Figure 3: (a) A general causal graph where the mediators in the dashed circle represent multiple
mediators with arbitrary causal dependence. Both L and A causally affect each mediator; each
mediator causally affect the outcome Y . Here we study the k-th mediator Mk, which has M1 and
M2 as its parents and M3 and M4 as its children. (b) The SWIG of panel a when intervening A
to a, so that the exposure value a and the observed A are separated; and the mediators becomes
potential outcome for a. We ignored the arrows pointing into the outcome. (c) The SWIG of panel
a when intervening A to a and Mk to k. Note that there are three versions of Mk: Mk is the
observed value when no intervention is applied; Mk(a,M1(a),M2(a)) is the potential outcome of
Mk when intervening A to a; and m is the intervened value of Mk.
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